• Tidak ada hasil yang ditemukan

Draft Formularium 2016

N/A
N/A
Protected

Academic year: 2021

Membagikan "Draft Formularium 2016"

Copied!
85
0
0

Teks penuh

(1)

DRAFT FORMULARIUM 2016

DRAFT FORMULARIUM 2016

(2)

DRAF FORMULARIUM RUMAH SAKIT IBU DAN ANAK DEDARI DRAF FORMULARIUM RUMAH SAKIT IBU DAN ANAK DEDARI

TAHUN 2016 TAHUN 2016

Kepada yang terhormat ketua SMF  Kepada yang terhormat ketua SMF 

TATA CARA PENGISIAN DRAF FORMULARIUM RUMAH SAKIT TAHUN 2016 TATA CARA PENGISIAN DRAF FORMULARIUM RUMAH SAKIT TAHUN 2016

1!

1! DraDra" "o" "ormurmu#ar#ar$um $um RumRumah Sah Sakak$t I%$t I%u dau dan An Ananak Dek Dedardar$ Ku$ Kupanpang meg mengnga&u a&u papada "da "ormormu#au#ar$ur$um nam na'$o'$onana#!#! 2!

2! O%aO%at p$t p$#$h#$han pan pertertamama ada ada#aa#ah o%h o%at gat geneener$k r$k %e%er#or#ogo ygo yanang mag ma'uk 'uk dada#am #am e#ee#ektrktronon$k &$k &ataata#og#og!! (!

(! O%aO%at p$t p$#$h#$han kan keduedua da dan kan ket$et$ga dga dapapat dat d$p$$p$#$h #$h o%ao%at %rt %ranandeded yd yanang mag ma'uk 'uk e#ee#ekrtkrtonon$k &$k &ataata#og#og!! )!

)! SMF dapSMF dapat mat mengaenga*uka*ukan pn penggenggant$ant$an an o%ao%at dat dar$ "r$ "ormuormu#ar$u#ar$um 2m 201( 01( atau atau menmengu'ugu'u#kan #kan o%at o%at #a$n#a$n+%ar+%aru unu untuk tuk "orm"ormu#ar$u#ar$umum tahun

tahun 2016! 2016!

,! O%at #a$n yang t$dak terma'uk da#am e#ektron$k &ata#og tap$ 'angat d$per#ukan dapat d$a*ukan dengan me#amp$rkan e-$den&e ,! O%at #a$n yang t$dak terma'uk da#am e#ektron$k &ata#og tap$ 'angat d$per#ukan dapat d$a*ukan dengan me#amp$rkan e-$den&e

 %a'e me d$&

 %a'e me d$&$ne penggu$ne penggunaan o%at tenaan o%at ter'e%ut!r'e%ut!

 .o!

 .o! Ke#a' TKe#a' Terap$/ Su% erap$/ Su% Ke#a' TKe#a' Terap$/ Daerap$/ Dan .aman .ama ener$k 

ener$k 

eennttuuk k SSeedd$$aaaann ..aamma a DDaaggaanngg Da#am Da#am Formu#ar$um Tahun Formu#ar$um Tahun 201( 201( U'u#an .ama U'u#an .ama Dagang Dagang Formu#ar$um Formu#ar$um 2016 D$ I'$ O#eh 2016 D$ I'$ O#eh SMF3 SMF3 4u%r$k  4u%r$k  1

1!! ..AARRKKOOTTIIKKAA/ / AA..TTII44IIRR55TTIIKK// A.TI.FLAMASI .O. ST5ROID/

A.TI.FLAMASI .O. ST5ROID/ A.TI4IRAIA.TI4IRAI

1

1!!11 AAnnaaggee''$$k k nnaarrkkoott$$k  k   F

Faannttaann$$## IInn**eekk''$ $ 00//00, , mmgg++mm##//  2 2 mm## FFeennttaann$$## K$$mKm$$a a ""aarrmmaa In*e

In*ek'$ k'$ 0/0, 0/0, mg+mmg+m#/ #/ 10 10 m#m# FentFentan$# an$# K$m$K$m$a a "arm"armaa 4

(3)

DRAF FORMULARIUM RUMAH SAKIT IBU DAN ANAK DEDARI DRAF FORMULARIUM RUMAH SAKIT IBU DAN ANAK DEDARI

TAHUN 2016 TAHUN 2016

Kepada yang terhormat ketua SMF  Kepada yang terhormat ketua SMF 

TATA CARA PENGISIAN DRAF FORMULARIUM RUMAH SAKIT TAHUN 2016 TATA CARA PENGISIAN DRAF FORMULARIUM RUMAH SAKIT TAHUN 2016

1!

1! DraDra" "o" "ormurmu#ar#ar$um $um RumRumah Sah Sakak$t I%$t I%u dau dan An Ananak Dek Dedardar$ Ku$ Kupanpang meg mengnga&u a&u papada "da "ormormu#au#ar$ur$um nam na'$o'$onana#!#! 2!

2! O%aO%at p$t p$#$h#$han pan pertertamama ada ada#aa#ah o%h o%at gat geneener$k r$k %e%er#or#ogo ygo yanang mag ma'uk 'uk dada#am #am e#ee#ektrktronon$k &$k &ataata#og#og!! (!

(! O%aO%at p$t p$#$h#$han kan keduedua da dan kan ket$et$ga dga dapapat dat d$p$$p$#$h #$h o%ao%at %rt %ranandeded yd yanang mag ma'uk 'uk e#ee#ekrtkrtonon$k &$k &ataata#og#og!! )!

)! SMF dapSMF dapat mat mengaenga*uka*ukan pn penggenggant$ant$an an o%ao%at dat dar$ "r$ "ormuormu#ar$u#ar$um 2m 201( 01( atau atau menmengu'ugu'u#kan #kan o%at o%at #a$n#a$n+%ar+%aru unu untuk tuk "orm"ormu#ar$u#ar$umum tahun

tahun 2016! 2016!

,! O%at #a$n yang t$dak terma'uk da#am e#ektron$k &ata#og tap$ 'angat d$per#ukan dapat d$a*ukan dengan me#amp$rkan e-$den&e ,! O%at #a$n yang t$dak terma'uk da#am e#ektron$k &ata#og tap$ 'angat d$per#ukan dapat d$a*ukan dengan me#amp$rkan e-$den&e

 %a'e me d$&

 %a'e me d$&$ne penggu$ne penggunaan o%at tenaan o%at ter'e%ut!r'e%ut!

 .o!

 .o! Ke#a' TKe#a' Terap$/ Su% erap$/ Su% Ke#a' TKe#a' Terap$/ Daerap$/ Dan .aman .ama ener$k 

ener$k 

eennttuuk k SSeedd$$aaaann ..aamma a DDaaggaanngg Da#am Da#am Formu#ar$um Tahun Formu#ar$um Tahun 201( 201( U'u#an .ama U'u#an .ama Dagang Dagang Formu#ar$um Formu#ar$um 2016 D$ I'$ O#eh 2016 D$ I'$ O#eh SMF3 SMF3 4u%r$k  4u%r$k  1

1!! ..AARRKKOOTTIIKKAA/ / AA..TTII44IIRR55TTIIKK// A.TI.FLAMASI .O. ST5ROID/

A.TI.FLAMASI .O. ST5ROID/ A.TI4IRAIA.TI4IRAI

1

1!!11 AAnnaaggee''$$k k nnaarrkkoott$$k  k   F

Faannttaann$$## IInn**eekk''$ $ 00//00, , mmgg++mm##//  2 2 mm## FFeennttaann$$## K$$mKm$$a a ""aarrmmaa In*e

In*ek'$ k'$ 0/0, 0/0, mg+mmg+m#/ #/ 10 10 m#m# FentFentan$# an$# K$m$K$m$a a "arm"armaa 4

(4)

7ed$on

7ed$on Ta%#et/ Ta%#et/ 10 10 mg mg 7ode$n 7ode$n K$m$a K$m$a "arma"arma

T

Taa%%##eett/ / ((0 0 mmgg 7o7oddee$$n n KK$$mm$$a a ""aarrmmaa M

Moorr""$$nn IInn**eekk''$$1100mmgg++mm##

Ta%#et 10 mg Ta%#et 10 mg

Mor"$n

Mor"$n K$m$a K$m$a "arma"arma

Mor"$n

Mor"$n K$m$a K$m$a "arma"arma

M

M''t t kkoonntt$$nnuu'' MMaahhaakkaam m %%eettaa "arma

"arma 4

4eetthh$$dd$$n n 8877II33 IInn**eekk''$$/ / ,,0 0 mmgg++mm## 44eetthh$$dd$$n n 8877II3 3 KK$$mm$$a a ""aarrmmaa K#oped$n

K#oped$n K$m$a K$m$a "arma"arma

7

7ooddee$$n n ((0 0 mmgg/ / 44aarraa''eettaammoo# # ,,000 0 mmgg// TTaa%%##eett 77oodd$$ttaam m KK$$mm$$a a ""aarrmmaa 1

1!!22 AA..AALL55TTIIK K ..OO. . ..AARRKKOOTTIIKKAA// A.TI4IR5TIK/ A.TII.FLAMASI .O. A.TI4IR5TIK/ A.TII.FLAMASI .O. ST5ROID

ST5ROID I%upro"en

I%upro"en TTaa%%##eet t 22000 0 mmgg II%%uupprroo""een n OO

T

Taa%%##eet t ))000 0 mmgg II%%uupprroo""eenn OO

Syrup 100 mg+ , m# Syrup 100 mg+ , m#

II%%uupprroo""eenn OO

F

Faarr''$$""eenn IInn""aarr''  pharma&e  pharma&eut$&a#ut$&a#

#a%orator$e' #a%orator$e'

II%%uu""eenn99 DDaannkkoo' ' ##aa%%oorraattoorr$$ee'' S

Syyrruup p 22000 0 mmgg+ + , , mm## II%%uupprroo""een n 88ee--''pphhaarrm m **aayyaa K

Keettooppoo""een n SSuuppppoo''##ttoorr$$a a 11000 0 mmg g 44rroottoo""een n SSuupppp KK$$mm$$a a ""aarrmmaa K

Kaa##ttrroo""eenn KKaa##%%e e ""aarrmmaa T

Taa%%##eet t 11000 0 mmgg KKeettoopprroo""eenn 88ee--pphhaarrm m **aayyaa R

Reemmaattoo" " 110000 eerrnnoo""aarrmm IInn**eekk''$ $ ,,0 0 mmgg++mm## KKeettoopprroo""eenn ..oo::ee####

 pharma&e

 pharma&eut$&a# #a%ut$&a# #a% Ka#tro"en

Ka#tro"en Ka#%e Ka#%e "arma"arma

K

Keettoorroo##aa&& OO

T

Toorraa''$$kk KKaa##%%e e ""aarrmmaa In*ek'$ 10 mg+m#/ amp 

In*ek'$ 10 mg+m#/ amp  1m#

1m#

R

(5)

In*ek'$ (0 mg+m#/ amp/  1 In*ek'$ (0 mg+m#/ amp/  1 m#

m#

K

Keettaarroo##aa&& OO

T

Toorraa''$$kk KKaa##%%e e ""aarrmmaa T

Taa%%##eett RReemmooppaa$$n n DDee--a a MMeedd$$&&aa

M

Mee##ookk''$$kkaam m TTaa%%##eet t ;;//, , mmgg MMee##ookk''$$&&aam m OO

7ame#o&

7ame#o& De-a De-a Med$&aMed$&a

<

<ee##&&oo-- ..oo::ee####

4harma&eu

4harma&eut$&a# t$&a# #a%#a% T

Taa%%##eet t 11, , mmgg MMee##ookk''$$&&aamm OO 7ame#o&

7ame#o& De-a De-a Med$&aMed$&a

<

<ee##&&oo-- ..oo::ee####

4harma&eu

4harma&eut$&a# t$&a# #a%#a% IInn**eekk''$ $ 11, , mmgg++11//, , m##m MMoo::$$&&oo-- ooeehhrr$$nnggeerr

Ing#ehe$m Ing#ehe$m Me-pharm Danko' Me-pharm Danko' La%orator$e' La%orator$e' S

Suuppp p 11, , mmgg MoMo::$$&&oo-- ooeehhrr$$nnggeerr Ing#ehe$m Ing#ehe$m M

Mee--pphhaarrmm DDaannkkoo''

La%orator$e' La%orator$e' M

Meettaammpp$$rroon n TTaa%%##eet t ,,000 0 mmgg MMeettaammpp$$rroonn OO

A

Annttaa##gg$$nn MMaarr$$n n LL$$99aa

IInn**eekk''$ $ ,,000 0 mmgg++mm## .o.o::aa##gg$$nn AA::eenntt$$' ' 44hhaarrmmaa A

Annttrraa$$nn IInntteerr%%aatt

M

Meettaammpp$$rroon n dd$$aa99eeppaam m 2 2 mmgg MMeettaammpp$$rroon n dd$$aa99eeppaam m 2 2 mmgg AAnnaa##''$$kk SSaann%%e e ""aarrmmaa D

Daannaa##gg$$nn DDaannkkoo''

La%orator$e' La%orator$e'  .atr$um D$k#o

 .atr$um D$k#o"enak"enak TaTa%#et 2, mg%#et 2, mg .atr$m d$k#o".atr$m d$k#o"ena&ena& OO R

Reenn::oo## OOtttto o 44hhaarrmmaa&&eeuutt$$&&aa Ind'

(6)

F#amar San%e "arma

Ta%#et ,0 mg .atr$um d$k#o"ena& O

Ren:o# Otto 4harma&eut$&a

Ind'

F#amar San%e Farma

Ka#$um D$k#o"enak Ta%#et 2, mg Ka#$um D$k#o"enak  

Ka"#am

O Ka#%e "arma

7ata"#am .o:art$' Indone'$a

Ta%#et ,0 mg Ka#$um D$k#o"enak O

Ka"#am Ka#%e "arma

7ata"#am "a't .o:art$' Indone'$a

In*ek'$ <o#taren $n* .o:art$' Indone'$a

Ta%#et ,00 mg 4ara&etamo# O

4ara&o 7oronet 7ro=n

4amo# $nter%at

Syrup 120 mg+, m# 4ara&etamo# O

4ara&o Inter%at

4amo# A&ta:$' Indone'$a

Suppo'$tor$a 12, mg 4amo# Inter%at

Dum$n Rt A&ta:$' Indone'$a

4amo# Inter%at

Suppo'$tor$a 2,0 mg Dum$n Rt A&ta:$' Indone'$a

Suppo'$tor$a >0 mg 4rop$ret$& &om%$phar  

Suppo'$tor$a 160 mg 4rop$ret$& 7om%$phar  

Tete' 100 mg+m# 4ara&etamo# O

(7)

4ara&o 7oronet 7ro=n

In"u' 4ara&etamo# O

4armado# "ahre$nhe$t

Sanmo# San%e Farma

A'am Me"enamat Ta%#et 2,0 mg A'am me"enamat O

Ta%#et ,00 mg A'am me"enamat O

4ona#ar 7oronet 7or=n

Su'pen'$ ,0 mg+, m# A'am me"enamat O

4onde- De-a Med$&a

Tramado# Kap'u#,0mg Tramado# O

Truna# De-a Med$&a

In*ek'$ ,0 mg+m# Tramado# O

Kamado# K$m$a Farma

Trama# 4haro' Indone'$a

Tramado# ? para&etamo# Ta%#et Ana#tram Lap$

Tram$"en Otto

4harma&eut$&a#'

1!( Ant$ p$ra#

A##opur$no# Ta%#et100mg A##opur$no# O

I'or$k Inter%at

Ta%#et (00 mg A##opur$no# O

I'or$k Inter%at

Ko#k$'$n Ta%#et ,00 mg Re&o#"ar Fahre$he$t

4ro%ene'$d Ta%#et ,00 mg 4ro%en$d De-a med$&a

4ro-$&am Ta%#et 10 mg 4$ro-$&am O

Ta%#et 20 mg 4$ro-$&am O

2! A.5ST5TIK  

2!1 A.5ST5TIK LOKAL

up#:$ka$n In*ek'$0/,0@ up$:$ka$n O

(8)

u:ane't Ka#%e Farma In*ek'$ 0/,0 @ 87I ? #uko'a3 una'kan 'p$na# 0/,@ hea:y Fahrenhe$t

5t$#k#or$da Semprot100m# 5t$#k#or$da O

L$do&a$n In*ek'$ ,@ ? #uko'a ,@ L$do&a$n O

In"$#tr2@ L$do&a$n O

e#$ 2@ B$#o&a$n A'tra'9ene&a

Semprot 10@ B$#o&a$n A'tra'9ene&a

2!2 A.5ST5TIK UMUM DA. OKSI5.

Sa:o"#urane 2,0 mg Ih Se:o"#urane a-ter Ka#%e Farma

I'o"#uran Inha#a'$ 2,0 m# Aerrane Ka#%e Farma

Ketam$n Ktm uard$an

4harmatama

In*ek'$ ,0 mg+m# Ane'*ek Danpa& 4harma

In*ek'$ 100 mg+m# Ktm uard$an

4harmatama

Ane'*ek Danpa& 4harma

M$dato#am In*ek'$ 1 mg+m# Fortane't Ka#%e Farma

Ane'"er Fahrenhe$t

In*ek'$ , mg+m# Fortane't Ka#%e "arma

Ane'"er Fahrenhe$t

Ok'$gen Ih ga' da#am ta%ung Ok'$gen O

4ropo"o# In*ek'$ 1 @ 4ropo"o# O

Re&o"o# De-a Med$&a

4ro"ane' San%e Farma

In*ek'$10@ 4ropo"o# O

Re&o"o# De-a Med$&a

4ro"ane' San%e Farma

2!( 4ROS5DUR 4R5 O45RATIF/ OAT untuk  

(9)

In*ek'$ 1 mg+m# Atrop$ne O

D$a9epam Ta%#et , mg+m# D$a9epam K$m$a Farma

<a#$'an%e ta% San%e Farma

Ste'o#$d A&ta:$' Indone'$a

In*ek'$ , mg+m# D$a9epam K$m$a Farma

Ste'o#$d A&ta:$' Indone'$a

<a#d$me- Mer'$"arma

T$rmaku Mer&u'uana

Mor"$n In*ek'$ 10 mg+m# Mor"$n K$m$a Farma

Fortane't Ka#%e Farma

M$da9o#am In*ek'$ , mg+ , m# Ane'"ar Fahre$nhe$t

( ANTIALERGI dan OBAT UNTUK ANAFILAKSIS

De-ameta'on

In*ek'$ , mg+m#

De-ameta'on O

Ka#meta'on Ka#%e Farma

Inde-on Inter%at

d$"enh$dram$n

In*ek'$ 10 mg+m#

D$"enh$dram$n O

Ad$dry# Ad$tama Raya

4harm$ndo

5p$ner"$n adrena#$n3 In*ek'$ 0/1 mg+m# 5p$ne"r$n adrena#$n3 O

8ydrokort$'on In*ek'$ 100 mg+:$a# 8ydrokort$'an O

k#or"en$ram$n Ta%#et ) mg K#orten$ram$n O

&etr$9$n

Ta%#et

7etr$9$n O

In&$da# od ayer Indone'$a

Intr$9$n $nter%at

Syrup , mg+m# 7et$r$9$n O

Ler'$n I"ar'

4harma&eut$&a# La%orator$um

(10)

)! A.TIDOT dan OAT LAI. untuk K5RA.7UA.

)!1 K8USUS

Atrop$n Ta%#et0/,mg Atrop$n O

In*ek'$ 1 mg+m# Atrop$n O

In*ek'$ 0/2, mg+m# Atrop$n O

5"edr$n In*ek'$ ,0 mg+m# 5"edr$n O

Ka#'$um Fo#$nat In*ek'$ ( mg+m# Re'&o:u#$n Rtu' 7om%$phar  

Leu&o:or$ne Ka#%e "arma

In*ek'$ 10 @ 100 mg+m#3 Leu&o:or$ne Ka#%e "arma

 Re'&o:u#$n Rtu' 7om%$phar

Kar%on akt$" Ser%uk akt$"/ 'a&h 0/, g ekar%on K$m$a "arma

 .eo D$a"orm 7oronet 7ro=n

Magne'$um 'u#"at In*ek'$ 20 @ Magne'$um 'u#"at Ot'uka Indone'$a

In*ek'$ )0 @ Magne'$um 'u#"at Ot'uka Indone'$a

Ser%uk Magne'$um 'u#"at rata&o &hem$&a#

Me'na In*ek'$ )00 mg Urom$te-en &om%h$phar  

 .a#ok'on In*ek'$ 0/) mg+m# .ako%a Tran'"arma med$ka

$ndah

In*ek'$ 0/02 mg+m# .ako%a O

 .atr$um %$kar%onat Ta%#et ,00 mg .atr$um %$kar%onat

 .atr$um th$o'u#"at In*ek'$ 2, @ .atr$um K$m$a "arma

th$u'u#"at 7oronet &ro=n

 .eo't$gm$n In*ek'$ 0/, mg+m# .eo't$gm$n rata&o &hem$&a#

4ro't$gm$n 5th$&a $ndu'try

"arma'$

4rotam$n 'u#"at In*ek'$ 10 mg+m# 4rotam$n 'u#"at O

)!2 UMUM

Kar%onakt$" Ta%#et0/,g ekar%on K$m$a"arma

(11)

Magne'$um 'u#"at Ser%uk Magne'$um 'u#"at rata&o &hem$&a#

7a#&$um g#ukonat In*ek'$ 100 mg+m# 7a#&#$ g#u&ona' 5th$&a $ndu'try

"arma'$

 .atr$um th$o'u#"at In*ek'$ 2, @ .atr$um th$o'u#"at O

,! A.TI54IL54SI C A.TIKO.<ULSI

,!1 A.TI54IL54SICA.TIKO.<ULSI K$m$aFarma

D$a9epam

In*ek'$ 10 mg+m#

D$a9epan A&ta:$' Indone'$a

Ste'o#$d San%e "arma

<a#$'an%e K$m$a "arma

Ta%#et 2 mg

D$a9epan A&ta:$' Indone'$a

Ste'o#$d <a#$'an%e

San%e Farma

Ta%#et , mg+m#

D$a9epan K$m$a "arma

Ste'o#$d A&ta:$' Indone'$a

<a#$'an%e San%e Farma

Re&ta# , mg+2/, m# 'te'o#$d A&ta:$' Indone'$a

Re&ta# 10 mg+m# 'te'o#$d A&ta:$' Indone'$a

4en$t$on

Kap'u# (0 mg

Fen$t$on Ika 4haram$ndo

 putrama'

Kuto$n Me'$r"ama T$rmaku

Mer&u'ana

Kap'u# 100 mg

Fen$t$on Ika 4haram$ndo

 putrama'

Kuto$n Me'$r"ama T$rmaku

Mer&u'ana

D$#ant$n 4"$9er $ndone'$a

In*ek'$ ,0 mg+m#

Fen$t$on Ika 4haram$ndo

4utrama'

(12)

Mer&u'ana

Fen$t$on Ika 4haram$ndo

 putrama'

 In*ek'$ 2,0 mg+ , m# Kuto$n Me'$r"ama T$rmaku

Mer&u'ana

"eno%ar%$ta# Ta%#et (0 mg Feno%ar%$ta# O

Ta%#et ,0 mg Feno%ar%$ta# I"ar'

 pharma&eut$&a# #a%orator$e'

S$%$ta# Me'$r"ama T$rmaku

Mer&u'ana

Ta%#et 100 mg Lum$na# O

In*ek'$ 100 mg+m# Lum$na# O

S$%$ta# Me'$r"ama T$rmaku

Mer&u'ana

In*ek'$ ,0 mg+m# Feno%ar%$ta# O

4entha# 7om%$phar

7ar%ame9ep$n Ta%#et 200 mg 7ar%ame9ep$n O

amgeto# Me'$r"ama T$rmaku

Mer&u'ana

Tegreto# Sando9 $ndone'$a

Ta%#et 100 mg 7ar%ama9ep$n O

amgeto# Me'$r"ama T$rmaku

Mer&u'ana

Syrup 100 mg+, m# 7ar%ama9ep$n O

amgeto# Me'$r"ama T$rmaku

Mer&u'ana

Magne'$um 'u#"at In*ek'$ 20 @ Magne'$um 'u#"at Ot'uka Indone'$a

In*ek'$ )0 @ Magne'$um 'u#"at Ot'uka $ndone'$a

(13)

Ta%#et 5R 2,0 mg Depakote 5r A%%ott Indone'$a

Ta%#et ,00 mg Depakote 5r A%%ott Indone'$a

Syurup 2,0 mg+, m# Depakene A%%ott $ndone'$a

A'am :a#proat Ta%#et (00 mg Ika#ep Ika pharm$ndo

 putrama'

,!2 A.TI .5RI 4ADA SARAF

7ar%ama9ep$n Ta%#et 200 mg 7ar%ama9ep$n O

Tegreto# Sando9 Indone'$a

amgeto# Me'$r"ama T$rmaku

Mer&u'ana

a%apent$n Kap'u# 100 mg a%apet$n O

a%e-a# Sando9 Indone'$a

A#pet$n A&t$:$' Indone'$a

Kap'u# (00 mg a%apet$n O

 .apet$k Ka#%e Farma

a%e-a# Sando9 Indone'$a

6! A.TI I.F5KSI

6!1! A.T5LMI.TIK 

6!1!1 Ante#m$nt$k Inte't$na#

A#%enda'o#e Ta%#et )00 mg A#%enda9o# O

Me%enda9o# Ta%#et ,00 mg Me%enda9o# O

Ta%#et 100 mg Me%enda9o# O

Syrup 100 mg+, m# Me%enda9o# O

<ermo- an''en &$#ag

4yrante# Ta%#et 2,0 mg 4yrante# O

(14)

Ta%#et 12, mg 4yrante# O

7om%antr$n Indo"arma

Su'p 12, mg+, m# 4yrante# O

&om%antr$n Indo"arma

6!1!2 Ant$"$#ar$a

A#%enda9o#e Ta%#et )00 mg A#%enda9o#e O

D$et$#kar%amo9$n Ta%#et ,0 mg D$et$#kar%amo9$n O

Ta%#et 100 mg D$et$#kar%amo9$n O

6!1!( Ant$'$'to'oma

4ra9$kuante# Ta%#et 600 mg 4ra9$kuante# Indo"arma

6!2 A.TI AKT5RI

6!2!1 eta #aktam

Amo-$&$##$n Ta%#et ,00 mg Amok'$#$n O

Amo-an San%e "arma

Op$mo- Otto

 pharma&eut$&a#' #nd'

Ta%#et 2,0 mg Amok'$'$#$n 2,0 mg O

Amo-an d$'per'$%#e 2,0 mg San%e "arma op$mo- Otto  pharma&eut$&a#' #nd'

Syrup 12, mg+, m# Amok'$#$n 'yr O

Amo-an San%e "arma

Op$mo- Otto

 pharma&eut$&a#' #nd'

(15)

Amo-an San%e "arma

Op$mo- Otto

 pharma&eut$&a#' #nd'

Drop' 100 mg+m# Amo-an drog' San%e "arma

O'pamo- Sando9 Indone'$a

Amo-$&$##$n ? a'am k#a:u#anat Ta%#et 62, mg 7o C amo-$&#ay O

7#ane-$ San%e "arma

7#a%at Inter%at

Amo-$&$##$n 12, mg ? a'am k#a:u#anat (1/2, mg Syrup 7o C amo-$&#ay O

7#ane-$ San%e "arma

Amo-$&$##$n 12, mg ? a'am k#a:u#anat 62/, mg Ta%#et 7o C amo-$&#ay O

7#ane-$ San%e "arma

Amp$'$#$n In*ek'$ ,00 mg+:$a# Amp$'$#$n Indo"arma

4en%$ot$k erno"arm

Standa&$##$n Sando9 Indone'$a

In*ek'$ 1000 mg+:$a# Amp$'$#$n O

4en%$ot$k erno"arm

Standa&$##$n Sando9 Indone'$a

Kap#et ,00 mg Amp$'$#$n O

4en%$ot$k erno"arm

Ka#p$&$#$n Ka#%e "arma

Syrup 12, mg+ , m# Amp$'$#$n O

4en%$ot$k erno"arm

Ka#p$&$#$n Ka#%e "arma

Amp$'$#$n ? 'u#%aktam

en9at$n pen$'$#$n In*ek'$ 1/2 *uta u#+m# en9at$n pen$'$#$n O

4enadur Sunth$ Sepur$

(16)

4enadur Sunth$ Sepur$

D$k#o# 'a'$#$n Ta%#et ,00 mg D$k#ok'a'$#$n O

Fenok'$met$# pen$'$#$n pen'$on <3 Ta%#et 12, mg Fenok'$metr$

 pen$'$#$n

O

Feno&$n A&ta"$' Indone'$a

4en$'$#$n < 12, Me$*$ Indone'$a

Ta%#et 2,0 mg Fenok'$metr$

 pen$'$#$n

O

Feno&$n A&ta"$' Indone'$a

4en$'$#$n < 2,0 Me$*$ Indone'$a

Ta%#et ,00 mg Fenok'$metr$

 pen$'$#$n

Me$*$ Indone'$a

Feno&$n Me$*$ Indone'$a

4en$'$#$n < ,00 Me$*$ Indone'$a

4roka$n %en9$#pen$'$#$n In*ek'$ 1 *uta u#+:$a# 4ro&a$n 4en$'$#$n E Me$*$ Indone'$a

In*ek'$ ( *uta u#+:$a# 4ro&a$n 4en$'$#$n E Me$*$ Indone'$a

Meropenem

In*ek'$ ,00 mg+:$a#

Moropenem O

Ronem Fahre$nhe$t

Mero"en Ka#%e Farma

In*ek'$ 1000 mg+:$a#

Mereponem O

Ronem Fahre$nhe$t Ka#%e

merotem Farme

7e"ta9o#$n

In*ek'$ 1 g+:$a#

Se"ta9o#$n O

Se"a9o# Ka#%e Farma

7e"tr$a-one

In*ek'$ 1 g+:$a#

7etr$a-one O

Tya'on 7am%$phar  

(17)

6!2!( Tetra'$k#$n Dok'$'#k#$n

Kap'u# 100 mg

Dok'$'$k$#$n O

S$&#$don San%e Farma

Interdo-$n $nter%at Ok'$tetra'$k#$n In*ek'$ ,00 mg+m# Ok'$tetra'$k#$n O O-$%$ot$k %erno"am Sa#ep ku#$t (@ Ok'$tetra'$k#$n O

Taram$&$n 4"$9er Indone'$a

Kap'u# ,00 mg

Tetra'$k#$n O

Tetra'an%e San%e Farma

6!2!) K#oram"en$ko# K#oram"en$ko# Kap'u# 2,0 mg In*ek'$ 100 mg+m# K#oram"en$ko# O 7am$&et$ne 7o#'an&et$ne Lu&a' D*a*a San%e Farma

7o#'an&et$ne San%e Farma

&hor%n$ot$& erno"arm

6!2!, Su#"a E tr$metopr$m

Kotr$mok'a9o#DO5.I 7ontr$rno-a9o#e O

de=a'a3 kom%$na'$ 'u#"metok'a9o#e metok'a9o#e )00 mg tr$metopr$m >0 mg

Ta%#et Ottopr$m Otto pharma&eut$&a#'

$nd'

Sanpr$ma San%e "arma

Kotr$mak'a9o# DO5. II  'u#"metok'a9o#e 100 mg tr$metopr$m 20 mg Ta%#et 7ontr$rno-a9o#e Ottopr$m Indo "arma Otto pharma&eut$&a#' $nd'

Sanpr$ma San%e "arma

(18)

'u'pen'e  'u#"metok'a9o#e 200 mg/ tr$metopr$m )0 mg

Ottopr$m Otto pharma&eut$&a#'

$nd'

Sanpr$ma San%e "arma

Kotr$mak'a9o# "orte kom%$na'$  'u#"ametak'a9o# >00 mg/ tr$metopr$m 160 mg

Ta%#et 7ontr$rno-a9o#e erno"arm

Ottopr$m Otto pharma&eut$&a#'

$nd'

Sanpr$m San%e "arma

6!2!6 Makro#$d

5r$trom$'$n Kap'# 2,0 mg 5ntrom$'$n O

5r$tr$n erna"orm

5r$'an%e Inter%at

Kap'u# ,00 mg 5ntrom$'$n O

5r$tr$n erna"orm

5r$'an%e Inter%at

Syrup 200 mg + , m# 5ntrom$'$n O

Op$thro&$n Otto

 pharma&eut$&a#' $nd'

5r$'an%e San%e "arma

Sp$ram$'$n Ta%#et 2,0 mg Sp$ram$'$n O

Soro: Soho $ndu'try

 pharma'$

I'ma&ro# Tempo R- "arma

(19)

Soro: Soho $ndu'try  pharma'$

I'ma&ro# Tempo R- "arma

7#$noam$'$n Kap'u# 1,0 mg 7#$ndam$'$n O

7#$%er&$n erno"arm

7#$n$um Inter%at

Kap'u# (00 mg 7#$ndam$'$n O

7#$%er&$n erno"arm

7#$n$um Inter%at

Ro-$thromy&$n Ta%#et (00 mg S$tro (00 Inter%at

S$ma&ron Tempo R- "arma

a9$thromy&$n Ta%#et 2,0 mg A9$thromy&$n O

$&ho 2,0 .$&ho#a'

#a%orator$um

$y&$n Inter%at

Ta%#et ,00 mg A9$thromy&$n O

$y&$n Inter%at

$no9yt Sando9 Indone'$a

D' 200 mg+ , m#/  1, m# 5ntr$ma- 5th$&a# $ndu'try

"arma'$

D' 200 mg+ , m#/  60 m# A9$trhom$'$n Soho $ndu'try

 pharma'$

A9oma- D' De-a med$&a

6!2!; Am$nog#$ko'$da

entam$'$n In*ek'$ )0 mg+m# entam$&$n O

5t$gen 5th$&a $ndu'try

(20)

In*ek'$ >0 mg+m# entam$&$n O

5t$gen 5th$&a $ndu'try

"arma'$

Streptom$'$n Ser%uk $n*ek'$ 1000 mg+:$a# Streptomy&$n me$*$ Me$*$ Indone'$a

Ser%uk $n*ek'$ ,000 mg+:$a# Streptomy&$n me$*$ Me$*$ $ndone'$a

Am$ka'$n 'u#"at In*ek'$ ,00 mg+ 2 m# Am$ka'$n 'u#"at O

Am$ka'$n 'u#"at Danko'

La%orator$e'

6!2!> Ku$no#on

Le:o"#ok'a'$n Ta%#et ,00 mg Le:o"$ok'a'$n O

7ra:o- Lap$"arma

Le:o-a# Sando9 Indone'$a

In"u'e ,00 mg+ 100 m# Le:o"$ok'a'$n O

7ra:o- Ka#%e "arma

Le:o-a# Lap$

7$pro"#ok'a'$n Ta%#et ,00 mg 7$pro"#ok'a'$n O

Inter"#o- Inter%at

7oro"#o- 7oronet &ro=n

In"u'e 2 @/ 100 m# 7$pro"#ok'a'$n O

StarGu$n De-a med$&a

Re'ku$n Ka#%e "arma

O"#ok'a'$n Ta%#et 200 mg O"#ok'a'$n O

(21)

<o#o- Ka#%eFarma

Ta%#et )00 mg O"#ok'a'$n O

O'tr$d Otto  pharma&eut$&a#' <o#o- Inter%at 6!2!H 4e"a#o'por$n 7e"ndrok'$# Kap'u# ,00 mg Syrup ker$ng 12, mg+, m#/60 m# 7e"adrok'$# O Lap$&e" Lap$

7e"at San%e "arma

Syrup ker$ng 2,0 mg+ , m#/ 60 m#

7e"adrok'$# O

Lap$&e" Lap$

7e"at San%r"arma

&e"ota-$m Ser%uk$n*ek'$ 7e"ota-$me O

$o&e" Otto

 pharma&eut$&a#' $nd'

Ka#"o-$m Ka#%e "arma

&e"tr$ak'on Ser%uk $n*ek'$ 7e"tr$a-one O

Tya'on 7om%$phar

Ter"a&e" San%e "arma

7e"ta9$d$me Ser%uk $n*ek'$ 1000 mg+:$a# 7e"ta9$d$me O

$%a& Fahre$nhe$t

7e"uro-$me a-et$## Ta%#et 'a#ut 2,0 mg $nnat #a-o =e#&ome

Indone'$a

Ta%#et 'a#ut ,00 mg $nnat #a-o =e#&ome

$ndone'$a

6!2!10 #$kopept$da

<ankom$'$n h$drok#or$da Ser%uk $n*ek'$ ,00 mg+:$a# <an&ep "ahre$nhe$t

(22)

Su#"a'a#a9$n .o:e##

 pharma&eut$&a# #a%

Me'a#a9$ne "ahrenhe$t

6!( A.TI I.F5KSI K8USUS

6!(!1 Ant$#epra

Dap'on Ta%#et 100 mg Dap'on K$m$a "arma

R$"amp$'$n Ta%#et (00 mg R$"amp$'$n O

R$"$&a%$ot erna"ram

Ta%#et ),0 mg R$"amp$'$n O

R$"$&a%$ot San%e "arma

Ta%#et 600 mg R$"amp$'$n O

R$"$&a%$ot San%e "arma

6!(!2 Ant$tu%erko#o'$'

Ftam%uto# Ta%#et 2,0 mg 5tam%uto# O

Ta%#et ,00 mg 5tam%uto# O

I'on#a9$d Ta%#et 100 mg In'on$a9$d O

Ta%#et (00 mg In'on$a9$d O

4$ra9$nam$d Ta%#et ,00 mg 4$ra9$nam$d O

Strepetap tom$'$n In*ek'$ 1000 mg+:$a# Streptomy&$n me$*$ Me$*$ $ndone'$a

In*ek'$ 1,00 mg+:$a# Streptomy&$n me$*$ Me$*$ $ndone'$a

In*ek'$ ,00 mg+:$a# Streptomy&$n me$*$ Me$*$ $ndone'$a

Kom%$na'$ untuk de=a'a  paduan da#am do'$' tetap KDT+FD73 r$"amp$'$n 1,0 mg/$'on#a9$d 1,0 mg

Ta%#et R$ma&ta'$d Sando9 $ndone'$a

Kom%$na'$ untuk anak  paduan da#am do'$' tetap KDT+FD73 r$"amp$'$n ;, mg/ $'on#a9$d ,0 mg

(23)

 p$ra9$nam$d 1,0 mg

Kom%$na'$ untuk anak  paduan da#am do'$' tetap KDT+FD73 r$"amp$'$n ;, mg/ $n'on#a9$d ,0 mg

Ta%#et R$ma&ta9$d paed Sando9 $ndone'$a

Kom%$na'$  fixed dose

7om%$nat$on tr$"amp$'$n 1,0 mg/ $'on$a9$d ;, mg  p$ra9$nam$d )00 mg/ etam%uto# 2;, mg

Ta%#et R$"a'ter Indo "arma

R$m'tar ) Fd& Sando9 $ndone'$a

6!(!( Ant$'ept$& 'a#uran kem$h metanam$n mande#at

hek'am$n mande#at3 A'am p$pem$dat

Ta%#et Ur$nter Inter%at

Urotrakt$n San%e "arma

6!) A.TI FU.SI

6!)!1 Ant$ "ung'$ '$'tem$k  

Am"oter$'$n  In*ek'$ ,0 mg+ 10 m# "ungderm

kon$me-F#ukona9o# Kap'u# 1,0 mg K$"#u9o#

F#u$d'

O erno"arm

o:a9o#e uard$an

 pharmatama

In*ek'$ 2 mg+m# F#ukona9o# O

F#ukona9o# 7rypta#

Fahre$nhe$t

D$"#u&an Ka#%e "arma

Kap'u# ,0 mg F#ukona9o# O

7rypta# Fahre$nhe$t

"#u&ora# Ka#%e "arma

r$'&o"u#:$n Ta%#et 12, mg r$'eo"u#"$n O

r$:$n 4hapro'

Ta%#et ,00 mg r$'eo"u#"$n O

(24)

Ketokena9o# Ta%#et 200 mg Katekena9o# Inter%at

De-a9o# O

Inter9o#e Ka#%e "arma

Kr$m 2@/ tu%e  , g Katekena9o#

My&orat

O

Ka#%e Farma

Kr$m 2@/ tu%e  10 g Katekena9o# O

My&orat Ka#%e "arma

 .$'tat$n Ta%#et ,00!000 u$ .$'tat$n O

Deka'tat$n 8ar'en

Su'p 100!000 u$+m#12 m# .ynd$a uard$an

 pharmatama

5ny't$a Danko' #a%orator$e'

 .ym$ka San%e "arma

Ta%#et :ag$na 100!000 u$ .y'tat$n :ag$na# 4hapro'

<ag$'t$n Ka#%e "arma

A#%othy# Larutan A#%othy# 4harma#$ngo

M$kona9o# Sa#ap (0 g Ant$ "ung'$ 'a#ep

kom%$na'$

Mar$n #$9a

Kr$m 2 @

M$kona9o# K$m$a "arma

Mo#aderm Mo#e- ayu

 pharma&eut$&a#'

6!, A.TI 4ROTOOA

6!,!1 Ant$amu%a dan ant$m$ard$a'$'

Metran$da'u#e Ta%#et 2,0 mg M$tron$da'o#e O

Tr$&hoda9o#e San%e "arma

(25)

Ta%#et ,00 mg Metron$da'o#e O

Tr$&hoda9o#e San%e "arma

 .$da9o#e Ka#%e "arma

Syrup 12,+, m# Omen$9a# Mut$"a

 pharma&eut$&a#'

Far$9o# I"ar'

 pharma&eut$&a# #a%orator$e'

In"u'e , mg+m#/ 100 m# Metron$da'o#e O

D$a9o#e raund med$&a#

Indone'$a

Tr$&hoda9o#e San%e "arma

O:u#a ,00 mg <ag$'t$n 7om%$phar

<ag$'o# K$m$a "arma

6!,!2 Ant$ ma#ar$a

6!,!2!1 Untuk pen&egahan

dok'$'$k#$n Kap'u# 100 mg Dok'$'$k#$n O

Interdo-$# Inter%art

S$k#$don San%e "arma

6!,!2!2 Untuk pengo%atan

Ant$ ma#ar$a DO5. Ta%#et Su#"ado-$n K$m$a "arma

 pyr$metam$n Ro&he Indone'$a

Kom%$na'$  'u#"adok'$n ,00 mg/ pr$metam$n 2, mg

Ta%#et Fan&$dar Ro&he Indone'$a

Su#do- A#"aparma

Artemether/ In*ek'$ >0 mg+m# Artemether O

Arte'unat In*ek'$ 60 mg+m# Arte'unat O

Kom%$na'$ kom%$pak3 arte'unat ,0 mg/amod$aku$n 200 mg

(26)

Fu$n$n Ta%#et 200 mg Ku$n$n O

Ta%#et 222 mg Ku$n$n O

Ta%#et2,0mg Ku$n$n O

In*ek'$ 2,@ Ku$n$n O

4r$maku$n Ta%#et 1, mg 4r$maku$n O

Kom%$na'$  a! artemether 20 mg / %! #ume"antr$ne 120 mg

Ta%#et 7oartem .o:art$' Indone'$a

Artemether In*ek'$ >0 mg Artemether O

6!6 A.TI <IRUS

6!6!1 Ant$ herpe'

A'$k#o:$r Ta%#et 200 mg A'$k#o:$r O

Ipa:$r oter

Indo"arma Inter%at

Ta%#et )00 mg A'$k#o:$r O

Ipa:$r Indo"arma

oter Inter%at

6!6!2 A.TI 854ATITIS

6!6!(!1 4egy#ated $nter"eron C 2a In*ek'$ 1(, m&g+0/, m# 

0/, m#

4ega'y' Ro&he Indone'$a

4egy#ated $nter"eron C 2a In*ek'$ 1(, m&g+0/, m# 

0/, m#

4ega'y' Ro&he Indone'$a

R$%a:$r$n Ta%#et 200 mg 7opegu' Ro&he $ndone'$a

Te#%$:ud$n Ta%#et 600 mg Se%$:o .o:art$' $ndone'$a

Lam$:ud$n Ta%#et 100 mg 8ep#ay K$m$a "arma

Ade"o:$r d$p$:o-$# Ta%#et 10 mg 8ep'era #a-o =e#&ome

Indone'$a Andreetro:$ra#

 .u&#eot$de re:er'e tran'&r$pta'e $nh$%at .RTI3 Kom%$na'$

(27)

Lam$:ud$n ( 7T3 Ta%#et 1,0 mg K$m$a "arma

Sta:ud$n Ta%#et (0 mg K$m$a "arma

$do:ud$n Ta%#et 100 mg K$m$a "arma

6!6!(!2 .on nu&#eot$de re:er'e tran'&r$pta'e $nh$%$tor ..RTI3

5"a:$ren' Ta%#et200mg O

5"a:$ren' Ta%#et 600 mg O

 .e:$rap$n Ta%#et 200 mg O

6!6!(!( 4rotea'e $nh$%$tor

Kom%$na'$ 

Lop$na:$r 200 mg/ r$tona:$r ,0 mg L$r ap$no: 200 mg/

R$tona:$r ,0 mg

O

;! A.TIMIR5.

;!1 4ROFILAKSIS

D$h$droergotam$n Ta%#et 2/, mg 7$h$droergotm$n O

4ropano#o# Ta%#et 10 mg 4ropano#o# O

4armadra# Fahre$nhe$t

Indera# A'tra9ena&a

;!2 S5RA.A. AKUT

5rgotam$n Ta%#et 1 mg 5r$&a" Tempo R- "arma

Kom%$na'$ 

Orgotam$n 1 mg/ ka"e$n ,0 mg Ta%#et O

etah$'t$ne d$h$drok#or$da Ta%#et > mg etah$'t$ne

d$h$dro#or$da

O

<a't$go De-a med$&a

<er t$ka" K$m$a "arma

Ta%#et 6 mg <a't$go O

<er'$#on 6 Me'$"arma t$rmaku

(28)

 .o:erty .o:e##

 pharma&eut$&a# ta%

F#unar$9$n Ta%#et Frego Ka#%e "arma

Una#$um uard$an

 pharmatama

rat$'$n San%e "arma

7$nar$9$n Ta%#et Stugeron an''en &$#ag

7$nn$p$r$ne K$m$a "arma

4er$"a' Otto

 pharma&eut$&a#' $nd'

> A.TI.5O4LASTIK/IMU.OSU4R5SA. dan

OAT untuk T5RA4I 4ALIATIF

>!1 FORMA. dan A.TI8ORMO.

De-ameta'on In*ek'$,mg De-ameta'on O

De-ameto'on Inter%at

Ta%#et 0/, mg De-ameta'on 8e-pharm *aya

Inde-on O

Ka#meta'one Farma&$a

Medrok'$ proge'teron a'etat Ta%#et ,00 mg Medrok'$

 proge'terone a'etat

O

In*ek'$ 200 mg+m# Depoproge't$n 8ar'en

Depopro:era Farma&$a

Ta%#et ) mg Meth$#predn$'o#on O

(29)

Lame'on Lap$

Ta%#et > mg Int$dro# Inter%at

Lame'on Lap$

Meth$#predn$'o#on Ta%#et 16 mg Int$dro# Inter%at

Lame'on Lap$

In*ek'$ Meth$#predn$'o#on De-a med$&a

 .o:e'tro# .o:e##

 pharma&eut$&a# ta%

Lame'on Lap$

Tamok'$"en Ta%#et 20 mg Tamo"en Ka#%e "arma

>!2 IMU.OSU4R5SA.

K#oroku$n Ta%#et 2,0 mg K#oroku$n O

Ma#are- A&t$:$' Indone'$a

Re'o&h$n ayer Indone'$a

Metotrek'at Ta%#et 2/, mg Metotrek'at O

S$k#o'por$n Kap'u# 2, mg Sand$mun neura# .o:art$' $ndone'$a

In*ek'$ ,0 mg+m# Sand$mun neura# .o:art$' Indone'$a

Su#"a'a#a9$n Ta%#et ,00 mg La'a"$n .o:e##

 pharma&eut$&a# #a%

Su#"$t$' Fahre$nhe$

My&opheno#ate mor"et$# Kap'u# ,00 mg 7e## &ept Ro&he Indone'$a

>!( SITOSTATIK

#eom$'$n In*ek'$ 1, mg+amp #eo&$n Ka#%e "arma

Dakeroa'$n In*ek'$ 200 mg+20 m# Dakar%a'$n meda& D$pa pharma#a%

D%# da&ar%a9$n Tempo R- "arma

(30)

 pharma&eut$&a# #a%

Dok'oru%$'$n In*ek'$ 10 mg+:$a# Do-oru%$'$n h&# San%e "arma

Do-oru%$'$n A&ta:$' Indone'$a

In*ek'$ ,0 mg+:$a# Do-oru%$'$n ka$%e Ka#%e "arma

Do-oru%$'$n rtu' 7om%$phar

Do-oru%$'$n a&ta:$' A&ta:$' Indone'$a

Do&eta-e# In*ek'$ 20 mg+0/, m# Do&eta-e# San%e "arma

re-e# ka#%e "arma

In*ek'$ >0 mg+2 m# re-e# Ka#%e "arma

5topo'$d In*ek'$ 20 mg+m# 4o'yd rtu' 7om%$phar

5topu# .o:e##

 pharma&eut$&a# #a%

Kap'u# 100 mg 4o'yd rtu' 7om%$phar  

8uaroura'$# In*ek'$ ,0 mg+m# 7ura&$# Ka#%e "arma

In*ek'$ 2,0 mg+m# 7ura&$# Ka#%e "arma

In*ek'$ ,00 mg+m# F#ura&edy# rtu' 7om%$phar

7ura&$# Ka#%e "arma

8$drok'$urea Kap'u# ,00 ,00 mg 7ytodro- 7om%ophar

8o'"am$d In*ek'$ 1000 mg+:$a# 8o#o-an Tran'"arma med$ka

$ndah

Ka#'$um "o#$nat In*ek'$ ,0 mg+m# Re'&o:u#$n rtu' 7om%$phar

Leu&o:or$n ka#%e Ka#%e "arma

Me#"a#an Ta%#et 2 mg A#karen #a-o 'm$thk#$ne

 %e&ham

Me'na In*ek'$ )00 mg+ 2 m# Urom$to-an Tran'"arma med$ka

$ndah

Metotrek'at Ta%#et 2/, mg Metotrek'at O

(31)

In*ek'$ , mg+ 2 m# Metotrek'at ka#%e 5mthe-at rtu'

Ka#%e "arma

4ak#$tak'e# In*ek'$ (0 mg+ , m# 4ak#$ta'e#

4a-u'

7om%$phar

In*ek'$ 100 mg+:$a# S$nda-e#

4a-u'

San%e "arma

In*ek'$ ,00 mg+:$a# 7y&#o:$d Ka#%e "arma

In*ek'$ 1000 mg+:$a# 7y&#opho'pham$d Ka#%e "arma

7y&#o:$d A&ta:$' Indone'$a

S$'p#at$n In*ek'$ 10 mg+:$a# 7$'p#at$n .o:e##

 pharma&eut$&a# #a%

4#ato'$n rtu' Ka#%e "arma

In*ek'$ ,0 mg+:$a# 7$'p#at$n .o:e##

 pharma&eut$&a# #a%

4#ato'$n rtu' Ka#%e "arma

S$tara%$n In*ek'$ 1000 mg+:$a# O%# &ytar%$n 7om%$phar

<$n%#$n a't In*ek'$ 10 mg+:$a# <$n%#a'$n rtu' Ka#%e "arma

D%# :$n%#a't$n 7om%$phar

<$nkr$'t$n In*ek'$ 1 mg + :$a# <$nkr$'t$n ka#%e Tempo r- "arma

<$nkr$'t$n rtu' 7om%h$par

In*ek'$ 2 mg+:$a# <$nkr$'t$n ka#%e Ka#%e "arma

<$nkr$'t$n rtu' 7om%$phar

7ar%op#at$n In*ek'$ 1,0 mg+:$a# 7ar%op#at$n Ka#%e "arma

7ar%o'$n rtu' 7om%$phar

7ar%op#at$n In*ek'$ ),0 mg+:$a# 7a%op#at$n Ka#%er "arma

7ar%o'$n rtu' 7om%$phar

5p$ru$&$n Ser%uk $n*ek'$ 10 mg+:$a# 5p$ru%$&$n ka#%e Ka#%e "arma

5p$ru%$&$n h&# San%e "arma

(32)

M$tom$&$n & Ser%uk $n*ek'$ 10 mg+:$a# M$torny&$n & $datra %hakt$

7ape&$ta%$ne Ta%#et ,00 mg Be#oda Ro&he Indone'$a

em&$ta%$ne In*ek'$ 200 mg+:$a# em&$ta%$ne h&# San%e "arma

emta:$' A&ta:$' Indone'$a

In*ek'$ 1000 mg+:$a# emta:$' A&ta:$' Indone'$a

A%$ngem K$m$a "arma

<$nore#%$ne In*ek'$ 10 mg+:$a# .a:e#%$ne Tran'"arma med$ka

$ndah

O-a#$p#at$ne In*ek'$ ,0 mg+:$a# Re-ta Ka#%e "arma

In*ek'$ 100 mg+:$a# O-a#$p#at$n San%e "arma

Re-ta Ka#%e "arma

Ir$note&an 87I In*ek'$ )0 mg+:$a# Ir$note&an 8&# San%e "arma

7ampto 4"$9er Indone'$a

In*ek'$ 100 mg+:$a# Ir$note&an 8&# San%e "arma

7ampto 4"$9er Indone'$a

Tran'tu9uma% In*ek'$ ))0 mg+20 m# 8er&ept$n Ro&he Indone'$a

R$tu-$ma% In*ek'$ 100 mg+10 m# Ma%thera Ro&he Indone'$a

In*ek'$ ,00 mg+,0 m# Ma%thera Ro&he Indone'$a

D$'od$um&#odronate A&ta:$'Indone'$a

Tetrahydrate In*ek'$ (00 mg+, m# A&ta%ona ayer Indone'$a

ene"o' .o:art$' Indone'$a

A'am 'o#edronat In*ek'$ ) mg+, m# ometa Ro&he Indone'$a

In*ek'$ 6 mg+6 m# andronat #a-o 'm$thk#$ne

 %e&ham

Lapat$n$% d$to'y#ate Ta%#et 2,0 mg Tyker% Mer&k Indone'$a

7etu-$ma% In*ek'$ 100 mg+:$a# 5r%$tu- .o:e##

 pharma&eut$&a# #a%

5r$trop&et$n C a#"a In*ek' 2000 u$+m# 5potre- C.p Ka#%e "arma

(33)

In*ek' 2000 u$+m# Re&ormon A'tra9e9ene&a

$&a#utam$de Ta%#et ,0 mg 7o'ade- .o:art$' Indone'$a

Imat$n$% me'y#at Ta%#et 160 mg #$:e& Ro&he Indone'$a

e:a&$9uma% In*ek'$ 100 mg+) m# A:a't$n A'tra9e9ene&a

Me#pha#en Ta%#et 2 mg A#keran #a-o 'm$thk#$ne

 %e&ham

e"$t$n$% Ta%#et 2,0 mg Ire''a .o:art$' Indone'$a

 .$#ot$n$% Ta%#et 200 mg Ta'$gna

>!) T5RA4I 4ALIATIF/ OAT untuk

Mor"$n Ta%#et 10 mg Mor"$n K$m$a "arma

In*ek'$ 10 mg+m# m't &ont$nu' Mahakam %eta

"arma

H! A.TI4ARKI.SO. K$m$a "arma

Ant$park$n'on DO5.

Kom%$na'$  %en'era9$d 2, mg/ #e:adopa 100 mg Kap'u# Lepar'on O

Madopar 12, Ro&he Indone'$a

r$hek'$"en$d$# Ta%#et 2 mg Tr$hek'$"en$d$# 8&# O

8e-ymer C 2 Mer'$"arma t$rmaku

mer&u'ana

4ram$pe-o#e 87I Ta%#et 0/(;, mg S$"ro# 5r oehr$nger

$nge#he$m

Ta%#et 0/;,0 mg S$"ro# 5r oehr$nger

$nge#he$m Kom%$na'$  #e:odopa 100 mg/ &ar%$dopa 2, mg

ente&apone 200 mg

Ta%#et Sra#e:o .o:art$' Indone'$a

10! A.TIMIAST5.IA RA<IS

4yr$do't$gm$ne Ta%#et 60 mg Me't$non Tran'"arma med$ka

$ndah

11! DARA8/ OAT yang M5M45.ARU8I

11!1 A.TIA.5MI

(34)

Fo#a:$t San%e "arma

Star"o#et De-a med$&a

Ta%#et 0/, mg A'am "o#at O

Fo#a:$t San%e "arma

Star"o#at De-a med$&a

Ta%#et , mg A'am "o#at O

Fo#a:$t San%e "arma

Star"o#at De-a med$&a

e'$ II3 'u#"at ; 820 Ta%#et (00 mg Su#"a "eru'u' K$m$a "arma

8ema"ort 4hhapro'

Syrup 1, mg+ ,m#/ 100 m#

Ferok$d Danko' #a%orator$e'

Drop 1, mg+, m#/ 1, m# Ferok$d Danko' #a%orator$e'

Kom%$na'$

e'$ II3 'u#"at 200 mg/ <$t  12 1, m&g A'am "o#at 0/2, mg/&a &ar%onate 200 mg

4renam$a San%e "arma

Lo= mo#e&u#e $ron III3'u&ro'e In*ek'$ 100 mg+ , m# R$no"er ar$ndo "armatama

 .e"ro:er Ka#%e "arma

Lo= mo#e&u#ar =e$ght In*ek'$ 100 mg+ 2 m# 7o'mo"er Fahre$nhe$t

11!2 KOAULASI/ OAT yang M5M45.ARU8I

A'am tranek'amat Ta%#et ,00 mg A'am tranek'amat O

Ka#ne- Ka#%e "arma

Tran'am$n 4p$n

In*ek'$ 2,0 mg+ , m# A'am tranek'amat O

Trane-$d De-a med$&a

Ka#ne- Ka#%e "arma

(35)

Trane-$d

Ka#ne-De-a med$&a Ka#%e

F$tomenad$on In*ek'$ 10 mg+m# 4hytomenad$one O

In*ek'$ 2 mg+m# 4hytomenad$one K$m$a "arma

4hytomenad$one Fahre$nhe$t

 .eo K 7om%$phar 

 .epar$n / .a In*ek'$ ,000 u$+m# 8anar$n /.a O

In:$&#ot Fahre$nhe$t

4rotam$n 'u#"at In*ek'$ 10 mg+m# 4rotam$n 'u#"at O

ar"ar$n Ta%#et 2 mg S$mar& 2 Fahre$nhe$t

Ta%#et 1 mg S$mar& 1 Fahre$nhe$t

 .adropar$ne &a#&$um In*ek'$ H,00A-a+m#/0/(

m#

Fra-$par$ne #a-o =e#&ome

Indone'$a In*ek'$ H,00A-a+m#/0/)

m#

Fra-$par$ne #a-o =e#&ome

Indone'$a  In*ek'$ H,00A-a+m#/0/6

m#

Fra-$par$ne #a-o =e#&ome

Indone'$a

In*ek'$ 20mg+2m#/0/2 m# Le:one- A:enth$' pharma

In*ek'$ )0mg+0/) m#/ 0/) m#

Le:one- A:enth$' pharma

5no-apar$ne 'od$um In*ek'$ 60mg+0/6 m#/  0/6

m#

Le:one- A:enth$' pharma

Fondapar$nu- In*ek'$ 2/, mg+:$a# Ar$-tra #a-o =e#&ome

Indone'$a

4$:aro-a%an Ta%#et 10 mg Bare#to ayer Indone'$a

Da%$gatran ete-$#ate Kap'u# ;, mg 4rada-a oehr$nger

$nge#he$m

Kap'u# 110 mg 4rada-a oehr$nger

(36)

11!!( I.TOKSIKASI AT 5SI

De"erok'am$n me'$#at In*ek'$ ,00 mg+:$a# De"erok'am$n

me'$#at

O

12 A.T DA.TARA8 dan 45.A.TI 4LASMA

12 !1 4RODUK DARA8

Fa&tor <III kon'entra'$3 In*ek'$ 2,0 UI+:$a# ?

 pe#arut 10 m#

8aemo&t$n K$m$a "arma

Kogenate F' ayer Indone'$a

Ser%uk $n*ek'$ 2(0 C ()0 IU

Koate D:$ D$pa pharma#a%

12!!2 45.A.TI 4LASMA dan 4LASMA

5KS4A.D5R 

 Hidrokxy ethyl starch In"u'e 6@ $dahe' $datra %hakt$

F$mahe' F$nu'o#pr$ma "arma

$nterna'$ona#

8ae' 'ter$# Fre'en$u' ka%$

AJ%um$n 'erum norma# In*ek'$ 20@  100 m# A#%apure De-a med$&a

8uman a#%um$n K$m$a "arma

O&ta#%$n Danko' #a%orator$e'

<$n a#%um$n Kap'u# <$p a#%um$n Roya# med$&a#$nk

 pharma#a% 4#a'$na proten "ra&t$on human3 Larutan $n"u'e ,@/  2,0

m#

4#a'manate D$pa pharma#a%

1(!1 A.TI FU.SI OROFARI.5AL

 .$'tat$n Su'p 100!000 UI+m# .ynd$a uard$an

 pharmatama

5ny't$n Danko' #a%orator$e'

 .ym$&o San%e "arma

(37)

Ane'tet$k #o&a# g$g$

DO5. kom%$na'$  #$do&a$n 87I 2@ 5p$ne"r$n 1  ,0!000

In*ek'$ L$do&a$n C Adr O

4eha&a$n 4hapro'

5t$# k#or$da Semprot 0/0, C H/2 m# 5t$# k#or$da O

L$do&a$n In*ek'$ 2@ L$do&a$n O

Semprot 1,@ L$done't A'tra9ne&a

1) DIUR5TIK DA. OAT U.TUK SALURA.

K5MI8

1)!1 DIUR5TIK

Am$#or$d Ta%#et , mg Lor$m$d m$te A&ta:$' Indone'$a

Furo'em$d Ta%#et )0 mg Furo'am$d O

Far'$- Fahre$nhe$t

Ure'$k 7apr$"arm$ndo

In*ek'$ 20 mg+m# Furo'am$d O

Impugan A&ta:$' Indone'$a

La'$- A:ent$' pharma

8$drok#ort$9$d Ta%#et 2, mg 8$drok#ort$$9$d O

Man$to# Larutan $n"u'e 20@ Man$to# F$nu'o#pr$ma "arma

$nterna'$ona#

In"u'e M20 San%e "arma

Ot'u Man$to# 20 Ot'uka Indone'$a

Sp$rono#akton Ta%#et 2, mg Sp$rono#akton O

(38)

Letona# Otto Letona# Otto  pharma&  pharma&eut$&a#'eut$&a#' $nd' $nd' T

Taa%%##eet t 11000 0 mmg g SSpp$$rroonnoo##aakkttoonn OO Sp$re#a

Sp$re#a Danko' Danko' #a%orator$e'#a%orator$e'

L

Leettoonnaa## 44rraatt

1

1))!!22 OOAAT T UU..TTUUK K 88II4455RRTTOO44I I 44RROOSSTTAATT T

Teerraa99oo&&$$nn8877II TTaa%%##eett11mgmg 88yyttrroo'' DDee--aammeedd$$&&aa

8ytr$n

8ytr$n A%%ott A%%ott Indone'$aIndone'$a

8ytro'

8ytro' De-a De-a med$kamed$ka

Ta%#et

Ta%#et 2 2 mg mg 8ytr$n 8ytr$n O%%ott O%%ott Indone'$aIndone'$a

T

Taamm''uu##oo''$$nnee TTaa%%##eet t 00//2 2 mmgg 88aarrnnaa# # DD AA''ttee####aa' ' pphhaarrmmaa

T

Taa%%##eet t 00//) ) mmgg 88aarrnnaa# # OO&&aa' ' AA''ttee####aa' ' pphhaarrmmaa 4

4uummkk$$n n ''eeeed d ee--ttrraa& & 55FFLLA A HH))0033 TTaa%%##eet t IInnkkuurr$$n n IInntteerr%%aatt 1

1,, 88OORRMMOO../ / OOAAT T 55..DDOOKKRRII. . LLAAII. . ddaann KO.TRAS54TIK

KO.TRAS54TIK 1

1,,!!11 8O8ORRMMOO. . AA..TTIIDDIIUURR55TTIIKK 1

1,,!!22 A.A.TTIIDDIIAA55TT55S S OORRAALL 1

1,,!!22!!11 SSUULLFFOO..IILLUURR55AA 7#$%en&#am$d

7#$%en&#am$d Ta%#et Ta%#et 2/, 2/, mg mg 7#$%en&#am$d 7#$%en&#am$d OO

T

Taa%%##eet t , , mmgg ##$$%%eenn&&##aamm$$d d OO 7#$p#9$d

7#$p#9$d Ta%#et Ta%#et , , mg mg #$p$9$d #$p$9$d OO

#$&#a9$de

#$&#a9$de Ta%#et >0 Ta%#et >0 mg mg ored ored erno"armerno"arm

#u&ode-

#u&ode- De-a De-a med$&amed$&a

#$ku#don

#$ku#don Ta%#et Ta%#et (0 (0 mg mg Lodem Lodem De-a De-a med$&amed$&a

#urenorm oerhr$nger

#urenorm oerhr$nger

$nge#he$m $nge#he$m #$mep$

(39)

Mep$r$#$d 7om%$phar 

Mep$r$#$d 7om%$phar 

So#o'a

So#o'a Sano"$ Sano"$ A:A:ent$'ent$'

$ndone'$a $ndone'$a Ta%#et

Ta%#et 2 2 mg mg #$mep$r$de #$mep$r$de De-a med$&aDe-a med$&a

So#o'a O

So#o'a O

D$a:er'a

D$a:er'a Sano"$ Sano"$ A:A:ent$'ent$'

$ndone'$a $ndone'$a Ta%#et

Ta%#et ( ( mg mg #$mep$r$de #$mep$r$de OO

So#o'a

So#o'a Sano"$ Sano"$ A:A:ent$'ent$'

$ndone'$a $ndone'$a D

D$$aa::eerr''aa DDee--a a meedm d$$&&aa Ta%#et

Ta%#et ) ) mg mg #$mep$r$de #$mep$r$de OO

So#o'a

So#o'a Sano"$ Sano"$ A:A:ent$'ent$'

$ndone'$a $ndone'$a D

D$$aa::eerr''aa DDee--a a meedm d$$&&aa 1

1,,!!22!!22 IIUUAA..IIDD M

Meett""oorrmm$$n n TTaa%%##eet t ,,000 0 mmgg MMeettttoorrmm$$n n OO

D$a%em$n

D$a%em$n De-a De-a med$&amed$&a

#udepat$& 4rat

#udepat$& 4rat

T

Taa%%##eet t >>,,0 0 mmgg MMeettttoorrmm$$n n OO #$"orm$n

#$"orm$n Tempo Tempo R- R- FarmaFarma

1

1,,!2!2!(!( AALFLFA A LLUUKOKOSISIDDA A II..8I8IITITOORR A&ar%o'e

A&ar%o'e Ta%#et Ta%#et ,0 ,0 mg mg 5&#$d 5&#$d De-a De-a med$&amed$&a

#u&o%ay

#u&o%ay ayer ayer Indone'$aIndone'$a

A&r$o'

A&r$o' A&ta:$' A&ta:$' Indone'$aIndone'$a Ta%#et

Ta%#et 100 100 mg mg 5&#$d 5&#$d De-a med$&aDe-a med$&a #u&o%ay

(40)

A

A&&rr$$oo'' AA&&ttaa::$$' ' IInnddoonnee''$$aa 1

1,,!!22!!)) TTIIAAOOLLIIDDII..55DDIIOO.. 4#og#$ta9one

4#og#$ta9one Ta%#et Ta%#et 1, 1, mg mg 4$on$- 4$on$- Danko' Danko' #a%orator$e'#a%orator$e'

De&u$#n

De&u$#n De-a De-a med$&amed$&a

Ta%#et

Ta%#et (0 (0 mg mg 4$on$- 4$on$- Danko' #a%orator$e'Danko' #a%orator$e'

D

Dee&&uu$$##nn DDee--a a mmeedd$$&&aa 1

1,,!!(( A.A.TTI I DDIIAA55TT55SS/ / 44AARR55..TT55RRAALL 8

8uummaan n $$nn''uu##$$n n IInn**eekk''$ $ 11000 0 UUII++mm## AA&&ttrraapp$$n n 88mm In'u#ator 8m In'u#ator 8m M$-tard (0 8m M$-tard (0 8m IInn''uu##$$n n $$nntteerrmmeedd$$aattee IInn**eekk''$ $ 11000 0 uu$$++mm##//&&aattrr$$ddggee

 ( m#  ( m# San'u#$n . San'u#$n . San'u#$n R  San'u#$n R  Ana#og $n'u#$n Ana#og $n'u#$n a'a#

a'a# $n'u#$n $n'u#$n ana#og ana#og In*ek'$ In*ek'$ 100 100 u$+m#/'o#o'taru$+m#/'o#o'tar  pen  ( m

 pen  ( m##

Lantu' 'o#on'tar pen Lantu' 'o#on'tar pen In*ek'$ 100 u$+m#/"#e-pen In*ek'$ 100 u$+m#/"#e-pen  ( m#  ( m# La:ern$r "#a-pen La:ern$r "#a-pen Rap$d

Rap$d $n'u#$n $n'u#$n ana#og ana#og In*ek'$ In*ek'$ 100 100 u$+m#/'o#o'taru$+m#/'o#o'tar  pen 2  ( m

 pen 2  ( m##

Ap$dra 'o#o'tar pen Ap$dra 'o#o'tar pen In*ek'$ 100 u$+m#/"#e-pen

In*ek'$ 100 u$+m#/"#e-pen ( m#

( m#

 .o:om$- "#a  .o:om$- "#a-pen-pen In*ek'$ 100 u$+m#/:$a#  10

In*ek'$ 100 u$+m#/:$a#  10 m#

m#

 .o:arap$d :  .o:arap$d :$a#$a#

M$-

M$- $n'u#$n $n'u#$n ana#og ana#og In*ek'$ In*ek'$ 100 100 u$+m#/"#eu$+m#/"#e-pen-pen  ( m#

 ( m#

 .o:om$- "#a  .o:om$- "#a-pen-pen 1

1,,!!)) 8O8ORRMMOO. K. K55LLAAMMII. d. daan On OAAT T yyaanngg M5M45.ARU8I F5RTILITAS M5M45.ARU8I F5RTILITAS 1

1,,!!))!!11 55''ttrrooggeenn 5

(41)

Indone'$a Indone'$a 1

1,,!!))!!22 44rrooggee''tteerroonnee  .oret$'tero

 .oret$'teron n TaTa%#et , mg%#et , mg .ore't$# .ore't$# uard$anuard$an

 pharmatam  pharmatamaa  .ore#ut

 .ore#ut De-a Med$&De-a Med$&aa

4

4rr$$mmoo##uut t .. aayyeer r IInnddoonnee''$$aa 1 1,,!!))!!(( KKoonnttrraa''eepptt$$kk 1,!)!(!1 1,!)!(!1 1,!)!(!2 1,!)!(!2 Lantra'ep

Lantra'ept$k/ t$k/ ora#ora#

4$# k% I kom%$na'$  #e:onorge'tre# 1,0 m&g 4$# k% I kom%$na'$  #e:onorge'tre# 1,0 m&g 5t$n$#e'trad$&

5t$n$#e'trad$&# # (0 m&g(0 m&g

4$# 4$# 4$# 4$# k% k% II/ II/ M$n$p$# M$n$p$#  Le:onorge'tre# 1,0 Le:onorge'tre# 1,0 m&g m&g 5t$n$#a'trad$n$ (0 5t$n$#a'trad$n$ (0 M&g M&g O O M$&rogynon

M$&rogynon ayer ayer Indone'$aIndone'$a

4

4$$# # kk% % IIII/ / mm$$nn$$pp##$ $   LLyynnee''ttrreennoo# # 00//, , mmgg 44$$# # 44$$# # kkaa% % IIII//MM$$nn$$pp$$# #  Lyne'treno# 0/, Mg Lyne'treno# 0/, Mg O O 5-#uton Organon 5-#uton Organon 4

4$$# # kk% % IIIIII/ / mm$$nn$$pp$$# #  44$$# # 4$$# 4# kk% % IIIIII/ / M$$nMn$$pp$$# #  OO D

Dee''ooggee''ttrreeoo# # ;;, , mm&&gg DDee''ooggee''ttrreeoo# # ;;,, M&g

M&g

O O 4$# k% I</ kom%$na'$  de'oge'treo# 1,0 m&g

4$# k% I</ kom%$na'$  de'oge'treo# 1,0 m&g et$n$#e'trad$o# (0 m&g et$n$#e'trad$o# (0 m&g 4$# k% 4$# k% I</I</ kom%$na'$  kom%$na'$  de'oge'treo# 1,0 de'oge'treo# 1,0 m&g et$n$#e'trad$o# m&g et$n$#e'trad$o# (0 m&g (0 m&g O O 4ontra'ept$

4ontra'ept$k k parentera#parentera# O

O%%aatt''uunntt$$kkKKII OO%%aatt''uunntt$$kkKK%%II OO

Medrok'$ proge'terone Medrok'$ proge'terone A'e&at 1,0 mg A'e&at 1,0 mg Medrok'$ Medrok'$  proge'tero

 proge'terone Ane A'etat'etat 1,0 Mg

1,0 Mg

O O

(42)

O%at 'unt$k K II/ kom%$na'$  O%at 'unt$k K% II/ Kom%$na'$ 

O

Medrok'$ proge'terone a'etat 2, mg Medrok'$

 proge'terone a'etat 2, mg

5'trad#o# &yp#onate , mg 5'trad#o# &yp#onate

, mg

O%at 'unt$k K III  O%at 'unt$k K III 

Medrok'$ proge'terone a'etat In*ek'$ depot 1,0 mg Medrok'$

 proge'terone a'etat

O In*ek'$ Depot 1,0 Mg

1,!)!(!( Kontra'ept$k/ AKDR IUD3

copperT  Set+%uat copperT  O

1,!)!(!) Kontra'ept$k/ $mp#ant

Le:onorge'tre$ Imp#ant ;, mg Le:onore# rge't O

5tonoge'tre$ Imp#ant 6> mg 5tonoge'tre# O

1,!)!) La$n C #a$n

K#om$"en '$trat Ta%#et ,0 mg K#om$"en 8e-apharma *aya

4ro:e#t$# Ka#%e "arma

4ro:u#a De-a med$&a

1,!, 8ORMO.5 TIROID dan A.TITIROID

Lugo# Larutan Lugo# O

 .atr$um t$rok'$n Ta%#et 0/1 mg 5uthyro- Mer&k Indone'$a

Thyra- S&her$ng p#ough

4rop##$t$oura'$# Ta%#et 100 mg 4rop##$t$oura'$# Indo"arma

Kar%$ma9o# Ta%#et , mg .eo mer&a9o#e .$&ho#a'

#a%orator$e'

Th$ama9o# Ta%#et , mg Thyro9o# Mer&k Indone'$a

1,!6 KORTIKOST5ROID

(43)

Sane-one San%e "arma

Inde-on Inter%at

In*ek'$ , mg+m# De-ameta'on O

Lanade-on Land'on

Ka#meta'on Ka#%e "arma

8ydrokord'on In*ek'$ 100 mg+m# 8ydrokort$'on O

7ream 2/, @ 8ydrokort$'on &ream 2/, @ K$m$a "arma  .e'ta&ort I"ar'  pharma&eut$&a# #a%orator$e'

Meth$#predn$'o#on Ta%#et ) mg Meth$#predn$'o#one O

Sane-on

San%e "arma

Intr$d$o# Inter%at

Ta%#et > mg Meth$#predn$'o#one O

Sane-on San%e "arma

Lame'on Lap$

Ta%#et 16 mg Meth$#predn$'o#one San%e "arma

Sane-on Inter%at

Int$dro# O

In*ek'$ 12, mg+:$a# Meth$#predn$'o#one

(44)

Somero# Soho $ndu'try  pharma'$

4redn$'on Ta%#et , mg 4redn$'one O

4eha&ort 4hapro'

16 KARDIO<ASKUL5R/ OAT

16!1 A.TIA.I.A

Am#od$p$n Ta%#et , mg Am#od$p$n Inter%at

Inter:a'k O

Ta%#et 10 mg Am#od$p$n erno"arm

Inter:a'k Inter%at

Ateno#o# Ta%#et ,0 mg Fernom$n Fahre$nhe$t

Ten'$norm Med$kon pr$ma

#a%orator$e'

D$#t$a9em Ta%#et (0 mg D$#t$a9em O

D$#t$a9em Indo"arma

Farma%e' Fahre$nhe$t

o'or%$d d$n$trat Ta%#et , mg I'o'or%$d d$n$trat O

Far'o%$t Fahre$nhe$t

7edokard , mg Darya :ar$a

Ta%#et 10 mg I'o'or%$d d$n$trat O

Far'or%$t Fahre$nhe$t

In*ek'$ 10 mg+10 m# I'o'or%$d d$n$trat O

Far'or%$t Fahre$nhe$t

7edo&art Darya :ar$a

#$'er$# tr$n$tat Ta%#et 2/, mg .$troka" retard K$m$a "arma

(45)

 .$trog#$'er$n Ta%#et 0/, mg .$tro&$ne 4hapro'

M$n$tran Darya :ar$a

4ropano#o# Ta%#et10 , mg 4ropano#o# O

Farmadra# Fahre$nhe$t

Ta%#et )0 mg 4ropano#o# O

Indera# A'tra9ene&a

16!2 A.TIARITMIA

Am#odaron Ta%#et 200 mg Kendarone Darya :ar$a

T$ary' Fahre$nhe$t

7ordaron Sano"$ A:ent$'

Indone'$a

In*ek'$ 1,0 mg+m# Kendarone Darya :ar$a

T$ary' Fahre$nhe$t

7ordaron Sano"$ A:ent$'

Indone'$a

D$gok'$n Ta%#et 0/, mg D$gok'$n O

D$gok'$n ar$ndo "armatama

Fargo-$n Fahre$nhe$t

In*ek'$ 0/2, mg+m# D$gok'$n O

D$gok'$n ar$ndo "armatama

Fargo-$n Fahre$nhe$t

D$'op$ram$d Kap'u# 100 mg D$'op$ram$d O

5p$ne"r$n adrena#$n3 In*ek'$ 0/1 @ 5p$ne"r$n O

4h$ne: 4hapro'

(46)

In*ek'$ 100 mg L$do&a$n O

L$dode- erno"arm

4ropano#o# Ta%#et 10 mg 4ropano#o# O

Farmadra# Fahre$nhe$t

Ta%#et )0mg 4ropano#o# O

In*ek'$ 1mg+m# 4ropano#o# O

<erapam$# Ta%#et)0mg <erapam$# O

Ta%#et >0mg <erapam$# K$m$a Farma

<em$# Rama 5mera#d

Mu#t$ Suk'e'

In*ek'$ 2/,mg+m# <erapam$# O

16!( A.TI8I45RT5.SI

Am$od$p$n %e'y#at Ta%#et ,mg Am#od$p$n O

D$:a'k Ka#%e Farma

7omd$p$n 7om%$phar

Ta%#et 10mg Am#od$p$n O

Inter:a'k Inter%at

(47)

Am$od$p$n ma#eat Ta%#et ,mg Am$d$-a# Sando9 Indone'$a

Ta%#et 10mg Am$d$-a# Sando9 Indone'$a

<erapam$# Ta%#et >0mg <erapam$# O

<em$# Rama 5mera#d

Mu#t$ Suk'e'

Ateno#o# Ta%#et,0mg Farnom$n Fahre$nhe$t

Ta%#et 100mg Ten'$norm Med$kon 4r$ma

La%orator$e'

Farnorm$n Fahre$nhe$t

$'opro#o# Ta%#et,mg $'opro#o# O

eta one Danko' La%orator$e'

$'&or De-a Med$&a

Ma$ntate Tana%e Indone'$a

D$#t$a9em Ta%#et(0mg D$#t$a9em O

8er%e'er 7d Tana%e Indone'$a

Kap'u# 100mg D$#t$a9em Indo"arma

8er%e'er 7d Tana%e Indone'$a

Kap'u# 200mg 8er%e'er 7d Tana%e Indone'$a

In*ek'$ 2,mg+ ,mg Farma%e' Fahr$enhe$t

In*ek'$ ,0mg 8er%e'er Tana%e Indone'$a

 .$kard$p$n h$drok#or$da In*ek'$ 10mg+ 10m# 4erd$p$ne A'te##a' 4harma

Ten'$#o Fahre$nhe$t

 .$mod$p$ne Ta%#et (0mg .$motop ayer Indone'$a

In"u' 10mg+ 10m# .$motop I< ayer Indone'$a

7erema- I!< Danko' La%orator$e'

8$drok#ort$9$d Ta%#et 2,mg 8$drok#ort$9$d K$m$a Farma

8$drok#ort$9$d Indo"arma

7aptopr$# Ta%#et 12/,mg 7aptopr$# O

De-a&ap De-a Med$&a

Ta%#et2,mg 7aptopr$# O

De-a&ap De-a Med$&a

(48)

De-a&ap De-a Med$&a

K#on$d$n In*ek'$ 0/1, mg+m# 7atapre' oehr$nger

Inge#he$m

Ta%#et 0/1,mg K#on$d$n Indo"arma

7atapre' oehr$nger

Inge#he$m

L$'$nopr$# Ta%#et,mg L$'$nopr$# O

 .operten De-a Med$&a

Interpr$# Inter%at

Ta%#et 10mg L$'$nopr$# O

 .operten De-a Med$&a

Interpr$# Inter%at

Ta%#et 2,0mg Dopamet A&ta:$' Indone'$a

 .atr$um n$tropru'$d In*ek'$ .atr$um n$tropru'$d O

 .$"ed$p$n Ta%#et 10mg .$"ed$p$n O

Ta%#et oro' 20mg Ada#at 7ro' ayer Indone'$a

Ta%#et oro' (0mg Ada#at 7ro' ayer Indone'$a

Ram$pr$# Ta%#et 1/2,mg Ram$-a# 1/2, Sando9 Indone'$a

Ta%#et 2/,mg Tenapr$# De-a Med$&a

Ram$-a# Sando9 Indone'$a

<$:an&e A&ta:$' Indone'$a

Ta%#et ,mg Tenapr$# De-a Med$&a

Ram$-a# Sando9 Indone'$a

<$:an&e A&ta:$' Indone'$a

Ta%#et 10mg <$:an&e A&ta:$' Indone'$a

7arda&e Sano"$ A:ent$'

Indone'$a

Ram$-a# Sando9 Indone'$a

Im$dapr$# Ta%#et,mg Tanapre' Tana%eIndone'$a

Ta%#et 10mg Tanapre' Tana%e Indone'$a

4er$ndopr$# arg$n$ne Ta%#et ,mg $opre-um Ser:$er Indone'$a

(49)

Framadra Fahre$nhe$t

Ta%#et )0mg 4ropano#o# 8&# De-a Med$&a

<a#'artan Ta%#et >0mg <a#'artan .$ .o:art$' Indone'$a

Ta%#et 160mg <a#'artan .$ .o:art$' Indone'$a

Ir%e'artan Ta%#et 1,0mg Ir%e'artan O

Ir%edo- Sando9 Indone'$a

Ir:a%a# A:ent$' 4harma

Ta%#et (00mg Ir%e'artan O

Ir%edo- Sando9 Indone'$a

Te#m$'artan Ta%#et >0mg M$&ard$' oehr$nger

Inge#he$m

7ande'artan &$#e-et$# Ta%#et >mg 7ander$n O

7ande'artan T$ Takeda Indone'$a

Ta%#et16mg 7ander$n O

7ande'artan T$ Takeda Indone'$a

orapro't 'od$um Ta%#et 20m&g Dorner A'te##a' 4harma

Tera9o'$n 87L Ta%#et 1mg 8ytr$n A%%ot Indone'$a

8ytro9 De-a Med$&a

8ytr$n A%%ott Indone'$a

ta%#et 2 mg 8ytro9 De-aMed$&a

(50)

ta%#et 2 mg 7ardura 4"$9er Indone'$a

16!) A.TIAR5ASI 4LAT5L5T

A'ama'et$#'$#at a'eto'a#3 ta%#et >0 mg M$n$a'p$ Mer'$"armaT$rmaku

Mer&u'ana

7arty#o K$m$a Farma

A'p$#at Darya <ar$a

ta%#et 100 mg Aptor .$&ho#e'

La%orator$e'

rama'a# rahaFarma

A't$ka Darya <ar$a

7#op$dogre# ta%#et;,mg 7#op$dogre# O

<a&#o De-aMed$&a

4#a:$- Sano"$ A:ent$'

Indone'$a

7$#o'ta9o# ta%#et100mg 7$#a'ta9o# O

4#etaa# Ot'uka Indone'$a

Ant$p#ate De-aMed$&a

16!, TROMOLITIK  

Streptok$na'e In*ek'$ ;,0!000 UI+:$a# Streptok$na'e O

In*ek'$ 1/, *uta UI+:$a# Strepta'e De-aMed$&a

Atep#a'e In*ek'$ ,0 mg+:$a# A&t$#y'e oehr$ngerInge#he$

m

16!6 AAL A.TU./ OAT

$'opro#o# ta%#et,mg $'opro#o# O

etaEOne Danko' La%orator$e'

Ma$ntae Tana%e Indone'$a

ta%#et 2/, mg $'opro#o# O

etaEOne Danko' La%orator$e'

Ma$ntae Tana%e Indone'$a

7ar:ed$#o# ta%#et6/2,mg <E#ook Ka#%eFarma

D$gok'$n ta%#et0/062, mg D$gok'$n O

(51)

Fargo-$n Fahre$nhe$t

D$gok'$n Indo"arma

ta%#et 0/2, mg D$gok'$n O

Fargo-$n Fahre$nhe$t

D$gok'$n Indo"arma

In*ek'$ 0/2, mg+ m# D$gok'$n O

I'o'or%$dD$n$trat In*ek'$ 10 mg+ 10 m# Far'or%$t 4rat

Rem$pr$# ta%#et 1/2, mg Ram$-a# 1/2, Sando9 Indone'$a

ta%#et 2/, mg Tenapr$# De-aMed$&a

Ram$-a# Sando9 Indone'$a

<$:an&e A&ta:$' Indone'$a

ta%#et , mg Tenapr$# De-aMed$&a

Ram$-a# Sando9 Indone'$a

<$:an&e A&ta:$' Indone'$a

ta%#et 10 mg <$:an&e A&ta:$' Indone'$a

7arda&e Sano"$ A:ent$'

Indone'$a

Ram$-a# Sando9 Indone'$a

16!; A.TI 45.AKIT A.TU. R5MATIK  

A'ama'et$#'a#$'$#at a'eto'a#3 ta%#et ,00 mg A'eto'a# O

M$n$a'p$ Mer'$"armaT$rmaku

Mer&u'ana

7arty#o K$m$a Farma

16!> SOK KARDIO5.IK dan S54SIS/ OAT/

untuk 

Do%utam$n In*ek'$2)mg+m# Do%utam$n O

Dom$n$& Ka#%e Frma

Inode- De-aMed$&a

Dopam$n In*ek'$ )0 mg+ m# Do%utam$n

Dom$n$& Ka#%e Farma

Inode- De-aMed$&a

(52)

5p$ne"r$n K$m$a Farma

5p$ne"r$n In*ek'$0/1@ Ra$:a' De-aMed$&a

<a'&on Fahre$nhe$t

 .orep#ane"r$n In*ek'$ 1 mg+m# Ra$:a' De-aMed$&a

<a'&on Fahre$nhe$t

In*ek'$ ) mg+) m# Ra$:a' De-aMed$&a

<a'&on Fahre$nhe$t

In*ek'$ > mg+> m# Le:o'o# K$m$a Farma

Ra$:a' De-aMed$&a

<a'&on Fahre$nhe$t

16!H A.TI8I45RLI45D5MIA

em$"$%ro'$ ta%#et(00mg em$"$%ro'$# O

S&ant$p$d Tempo R- Farma

Mer9a'o# Mar$a L$9a

ta%#et 600 mg em"$%ro'$# O

S$m:a'tat$n ta%#et10mg S$m:a'tat$n O

Se#:$m I"ar'

4harma&eut$&a# La%orator$e'

5':at De-aMed$&a

ta%#et 20 mg S$m:a'tat$n O

5':at De-aMed$&a

Ko#e'tat Ka#%e Farma

4ra:a'tat$n 'od$um ta%#et 10 mg 7ho#e'par 4haro' Indone'$a

ta%#et 20 mg 4ra:$nat Inter%at

L$panthy# A%%ot Indone'$a

Feno"$%rate kap'u#100mg Tro#$p De-aMed$&a

kap'u# (00 mg 5:ot$# uard$an

4harmatama

Antro:a'tat$n ta%#et L$p$tor 4"$9erIndone'$a

Stator De-aMed$&a

(53)

1;!1 A.TIAK.5

A'amret$noat kr$m 0/0, @ Tra&ne 0/0, @ Inter%at

Ret$&on

4harma#o-1;!2 A.TIAKT5RI

Ant$%akter$ DO5./

Kom%$na'$  %a'$tra'$n ,00 u$+g  po#$m$k'$n  10!000 u$+ g 'a#ap Kom%$na'$  a'$tra'$n ,00 UI+ 4o#$m$k'$n  10!000 UI+ O

4erak 'u#"ad$a'$n kr$m 1@ tu%e  (, g urna9$n Darya <ar$a

kr$m 1@ tu%e  ,00 g urna9$n Darya <ar$a

Fram$'et$n'u#"at ka'a'ter$# 1@/ #em%ar 

10-10 &m

So"raETu##e A:ent$' 4harma

DaryantETu##e Darya <ar$a

ka'a'ter$# 1@ #em%ar  ,-, &m

DaryantETu##e Darya <ar$a

 .atr$um"u'$dat Sa#ep 20 mg+ g/ tu%e  , g Fu&$#e- Mo#e- Ayu

4harma&eut$&a#'

Fu':yom 7om%$phar  

Futaderm 7ream Inter%at

kr$m 20 mg+g/ tu%e  , g Fu&$#e- Mo#e- Ayu

4harma&eut$&a#'

Fu&$&om 7om%$phar  

Futaderm Inter%at

1;!( A.TIFU.I

Ant$"ung$ DO5./

kom%$na'$  a'am %en9oate 6@ A'am'a#$'$#at (@

'a#ep h$te"$e#d a#" Mar$n L$9a

M$kona9o# 'er%uk2@ M$kona9o# OD

Inter'o# 7ream Inter%at

kr$m2@ M$kona9o# OD

Inter9o#e Inter%at

(54)

etame'on &ream 0/1@/ tu%e , g etameta'on O Or'aderm I"ar' 4harma&eut$&a# La%orator$e' eta'on Otto 4harma&eut$&a#' Ind'

kr$m 0/0,@ tu%e 10 g etameta'on O

S&anderma Tempo R- Farma

8ydrokort$'on kr$m2/,@ 8ydrokort$'on O

 .e'ta&ort I"ar'

4harma&eut$&a# La%orator$e'

kr$m 1@ 8ydro&ort$'on Mar$n L$9a

Ka#am$n #ot$o 7a#am$nLot$on

De'ok'$meta'on kr$m 0/2,@/ 10 g Denom$- 7om%$phar  

De-o&ort K$m$a Farma

Top&ort San%eFarma

kr$m 0/2,@/ 1, g De'ok'$meta'on OD

Iner'on Inter%at

D$"#ukorto#on:a#ert .er$#on Inter%at

1;!, A.TISKAI5S dan A.TI45DIKULOSIS

4ermet$n kr$m ,/0@ S&a%$m$te a#en$um4harma'$a

Sa#ep 2E)/ kom%$na'$  a'am'a#$'$#at 2@  %e#erangendap )@

Sa#"2) Mar$nL$9a

1;!6 KAUSATIK  

4o#$kre'u#en konden'a'$metakre'o# 'u#"onate metana#3

Larutan%oto#/ 10 m# A#%othy# 4harma#$ndo

1;!; K5RATOLITIK dan K5RATO4LASTIK  

A'am'a#$'$#at 'a#ep ,@ A'amSa#$'$#at ,@ O

(55)

'a#ep 10@ A'amSa#$'$#at 10@ O

7oa#tar #arutan,@ Tar,@ O

4odo"$#$n t$ngtur 2,@ 4odo"$##$nT$ngtur

2,@

O

Urea kr$m10@/20g Mo$'Derm Inter%at

kr$m 10@/  )0 g Tupepe 7ream Med$kon 4r$ma

La%orator$e'

1;!> LAI.ELAI.

Dedak'a#$'$# 'er%uk 2/0@ Ta#k Sa#y&# 2@ Ika4ham$ndo4utra

ma'

Ta#k Sa#y&y# 2@ k$m$a"arma

L$Guor &ar%on$'detergen' 'u'p 2/0@ L&d 2@ O

'u'p ,/0@ L&d ,@

L$Guor "a%er$ &a$ran L$auorFa%er$7a$ran O

Le:ertran 'a#ep 10/0@ Le:ertranSa#ep

10/0@

Ika4harm$ndo4utra ma'

1> LARUTA. DIA.ALISIS 45RITO.5AL

d$ana#$'a per$tonea# #arutan$n"u' D$a#$'a 4er$tonea# O

hemod$a#$'a #arutan 8emod$a#$'a O

1H LARUTA. 5L5KTROLIT/ .UTRISI/ dan

LAI.ELAI. 20!1 ORAL aramora#$t Kom%$na'$  .atr$umk#or$da 0/,2 g ka#$umk#or$da 0/(0 g/ tr$natr$um'$tratd$h$drat 0/,> g/ g#uko'aanh$drat 2/;0g 'er%uk Ora#$t Ora#$t Indo"arma

Ramo#$t Rama 5mera#d

Mu#t$ Suk'e' aramora#$t

Referensi

Dokumen terkait

maka Pokja Pengadaan Barang, Jasa Konsultansi dan Jasa Lainnya Pada Unit Layanan Pengadaan Barang/Jasa Kabupaten Aceh Barat Daya Tahun Anggaran 2014 mengumumkan Paket tersebut di

c. Sedangkan Pajak Masukan atas perolehan Barang Kena Pajak dan/atau Jasa KenaPajak yang belum dapat dipastikan penggunaannya untuk Penyerahan yangTerutang Pajak dan Penyerahan

Survival Alchemy 2019 yang dianjurkan oleh Jawatankuasa Pembangunan Pelajar (JKPP) Jabatan Kimia, Fakulti Sains berakhir dengan jayanya dengan hampir kesemua pelajar jurusan kimia

Estimasi sumberdaya batubara harus didasarkan konsistensi sebaran lateral yang dapat ditelusuri pada jarak tertentu mengacu pada SNI 5015:2011 tentang

PT Mitra Adiperkasa Tbk (MAPI) menargetkan penjualan tahun ini naik 20-25% YoY dan laba bersih ditargetkan naik 20-25% YoY.. Pada tahun 2011, perseroan membukukan kenaikan

Metode yang digunakan untuk mencapai tujuan yang telah dirumuskan dalam P2M ini adalah metode ceramah, diskusi dan juga pelatihan (merancang media audio visual dan refleksi)

Skripsi ini berjudul “ Persepsi Dan Kesiapan Guru Mata Pelajaran Sains SMP Muhammadiyah Se-Kota Surabaya Tentang Pelaksanaan Kurikulum 2013 yang diajukan

No.G-94